Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 28 Stomach Neoplasms 7 Esophageal Neoplasms 6 Inflammatory Breast Neoplasms 4 Adenocarcinoma Of Esophagus 3 Triple Negative Breast Neoplasms 2 Neoplasms 2 Sarcoma 1 Her2-Positive Breast Cancer 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms, Male 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 13 Etoposide 10 Prednisone 8 Doxorubicin 8 Whole-Body Irradiation 7 Vincristine 7 Rituximab 7 Peripheral Blood Stem Cell Transplantation 7 Melphalan 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Mycophenolic Acid 6 fludarabine 5 Lenalidomide 5 Gemcitabine 5 Cytarabine 5 10-propargyl-10-deazaaminopterin 5 Tacrolimus 4 Granulocyte Colony-Stimulating Factor 4 Carmustine 4 Busulfan 4 Antilymphocyte Serum 4 pembrolizumab 3 etoposide phosphate 3 carmustine, poliferprosan 20 drug combination 3 Vorinostat 3 Sirolimus 3 Nivolumab 3 Filgrastim 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × Epirubicin × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡